Medifast director Parsa Kiai buys 661 shares indirectly

Steamboat Capital Partners GP, LLC is the partnership's general partner; Parsa Kiai may be deemed to have a pecuniary interest in the shares.

Available on EDGAR 11/06/2026 - 02:29 PM EST Accepted by SEC EDGAR 11/06/2026 - 02:28 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Medifast Inc. (MED) director Parsa Kiai reported an indirect purchase of 661 shares on November 4, 2026, held through Steamboat Capital Partners II, LP. The average price was $13.0255 per share; actual purchase prices ranged from $12.87 to $13.15. The reported indirect position after the purchase was 21,089 shares. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Net Buyer: 661 shares

Net Buy 1 txn

Insider Kiai Parsa

Role Director

Bought 661 shs ($9K)

Increase in Position 3.2%

Type	Security	Shares	Price	Value
Purchase	Common Stock F1, F2, F3	661	$13.0255	$9K

Holdings After Transaction: Common Stock — 21,089 shares (Indirect, Notes)

Holdings Before and After: Common Stock, 20,428 to 21,089 shares (Indirect, Notes)

Footnotes (3)

1. F1. Ownership of Steamboat Capital Partners II, LP (II).
2. F2. Steamboat Capital Partners GP, LLC (GP) is general partner of, and entitled to receive a performance allocation from II. Parsa Kiai ("Kiai") is the Managing Member of GP. Accordingly, Kiai may be deemed to have a pecuniary interest in the shares owned by II. Kiai disclaims beneficial ownership of securities reported hereon except to the extent of his pecuniary interest therein.
3. F3. This is an average price. Actual prices paid for the shares purchased on 11/04/26 and reported on this line range from $12.87 to $13.15. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Shares purchased: 661 shares Average purchase price: $13.0255 per share Actual purchase-price range: $12.87 to $13.15 per share +1 more

4 metrics

Shares purchased 661 shares November 4, 2026

Average purchase price $13.0255 per share 661 shares purchased on November 4, 2026

Actual purchase-price range $12.87 to $13.15 per share Shares purchased on November 4, 2026

Reported indirect position after purchase 21,089 shares Steamboat Capital Partners II, LP

Key Terms

pecuniary interest, beneficial ownership, performance allocation

3 terms

pecuniary interest financial

"may be deemed to have a pecuniary interest in the shares owned by II"

beneficial ownership regulatory

"disclaims beneficial ownership of securities reported hereon"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

performance allocation financial

"entitled to receive a performance allocation from II"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MED shares did Steamboat Capital Partners II buy, and at what price?

Steamboat Capital Partners II, LP purchased 661 MED shares on November 4, 2026, at an average price of $13.0255 per share. Actual purchase prices ranged from $12.87 to $13.15, and the reported indirect position after the purchase was 21,089 shares.

How is Parsa Kiai connected to the MED share purchase?

Steamboat Capital Partners GP, LLC is the general partner of Steamboat Capital Partners II, LP, and Parsa Kiai, a Medifast Inc. director, is the GP's managing member. Kiai may be deemed to have a pecuniary interest in the partnership's shares and disclaims beneficial ownership except to the extent of that interest.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kiai Parsa

(Last) (First) (Middle)

24 MAPLE AVE

(Street)

RYE NEW YORK 10580

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MEDIFAST INC [ MED ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/04/2026		P		661	A	$13.0255	21,089	I	Notes(1)(2)(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Ownership of Steamboat Capital Partners II, LP (II).

2. Steamboat Capital Partners GP, LLC (GP) is general partner of, and entitled to receive a performance allocation from II. Parsa Kiai ("Kiai") is the Managing Member of GP. Accordingly, Kiai may be deemed to have a pecuniary interest in the shares owned by II. Kiai disclaims beneficial ownership of securities reported hereon except to the extent of his pecuniary interest therein.

3. This is an average price. Actual prices paid for the shares purchased on 11/04/26 and reported on this line range from $12.87 to $13.15. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

	/s/ Parsa Kiai	11/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)